Environment
Mixed / Neutral
50%
Benefits
- No direct environmental impact identified.
Risks
- No direct environmental impact identified.
FederalUS CongressReferred
H.R. 9421: To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
Rep. Sheri Biggs (R-SC)
H.R. 9421 status: Referred.
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
35OUT OF 100
Score:35/100 civic fit
Risk:High Risk
Impact:High Impact 85/100
Earlier scoring method. Reanalyze to use the sector calculation.
Constitutionality40%
Bipartisan10%
Public opinion45%
Bill summary
This bill would mandate in-person requirements for medication abortion nationwide, fundamentally restructuring access to reproductive healthcare and telehealth delivery models.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Critical outlook
40%
Benefits
- Standardizes in-person regulatory oversight for certain medical procedures.
Risks
- Increases administrative and compliance costs for telehealth providers.
- Disrupts existing supply chain and pharmacy delivery business models.
Society
Critical outlook
30%
Benefits
- Ensures in-person physician monitoring for specific medical interventions.
Risks
- Significantly restricts access to reproductive healthcare for rural or low-income populations.
- Creates potential legal and logistical barriers to medical privacy and telehealth equity.
Technology Industry
Not scored in this analysis.
Generate analysis again to evaluate this sector.
Civic Accountability
Not scored in this analysis.
Generate analysis again to evaluate this sector.
Public Health & Safety
Not scored in this analysis.
Generate analysis again to evaluate this sector.
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Confidence
High
Information is complete and verified.
Analysis basis
Full bill text (Congress.gov)
Source used for this bill's analysis.
Warning
Implementation risks causing significant disruption to established reproductive telehealth services nationwide.
Analysis scope
Legal challenges regarding federal preemption of state telehealth laws are not fully addressed.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- House and SenateUpcoming
- Final agreementUpcoming
- PresidentUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.